Great post by "hottod" - many thanks!! This illustrates quite/very clearly, why Australian biotech companies (if or hopefully WHEN) they are able to achieve promising PHASE II data will always have to look for some partnership opportunity with much bigger Pharma/Biotech companies in primarily the USA or EUROPE (and a few in Asia as well). Of course, the latter must be interested to go into a partnership.
Just my opinion, of course. Comments most welcome as always.
wasa
Great post by "hottod" - many thanks!! This illustrates...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.002(4.55%) |
Mkt cap ! $33.82M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.2¢ | $60.71K | 1.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 196364 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 49699 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.2¢ |
Change
-0.002 ( 4.55 %) |
||||
| Open | High | Low | Volume | ||
| 4.4¢ | 4.4¢ | 4.2¢ | 644458 | ||
| Last updated 15.55pm 13/06/2024 ? | |||||
| PTX (ASX) Chart |